Related Blog Posts
Prostrate Cancer Treatment | Cancer Minus
17 hours ago ago from Cancer Minus
When cells in the prostate grow abnormally, they form multiple small cancerous tumors. If the cancer is left untreated, it will at some point metastasize and begin to spread to other organs in the body via the bloodstream and lymphatic system. Prostrate Cancer: Who's at Risk 1.Age: Prostrate cancer is got to the men who are at the age above 50. 2.Family history: A man is at higher risk if the father or brother is suffering from ...
Related contentPossible ovarian cancer treatment target identified | Science Codex
18 hours ago ago from Science Codex | Science news, science articles, all day, every day
RSS Feeds » Sitewide | Earth | Heavens | Body | Brain | Culture | Technology Home Earth Heavens Body Brain Culture Tech Possible ovarian cancer treatment target identified Posted On: December 8, 2009 - 10:30pm A multi-institutional study has identified a potential personalized treatment target for the most common form of ...
Related contentFacts And Alternatives Regarding Treatments For Prostate Cancer.
7 hours ago ago from Cancer Articles
Facts And Alternatives Regarding Treatments For Prostate Cancer. Patients each of which instinctively suffer fm. prostate cancer hurriedly have ideal many alternatives true to urgently treat their attachment but then they should systematically know each and all the opinions and inquire into therapies a great t. ago they intensively choose the inhuman treatment fact that suits them. In joining true to brilliantly this, little a sometimes ...
Related contentBritain Claiming Major Breakthrough In Prostate Cancer Treatment
23 hours ago ago from Cancer Treatment Today
In July, 2008, British researchers claimed to have won a major victory for prostate cancer treatment. According to recently release reports, a new drug, abiraterone, may be used to treat as many as 80% of patients suffering from advanced forms of prostate cancer. Researchers worldwide involved in the treatment of prostate cancer are cautiously optimistic, and welcoming what may arguably be the best news in prostate cancer treatment ...
Related content9th December 2009
3 hours ago ago from BFW Library - Oncology
GO BACK TO MAIN LIBRARY NEWSLETTER GO BACK TO THE LIBRARY HOMEPAGE National Lung Cancer Audit 2009 released This report summarises the findings of the National Lung Cancer Audit for patients diagnosed with lung cancer or mesothelioma who were first seen in 2008. By the end of June 2008, all cancer networks in England, Wales and Scotland were contributing to the audit. Long term ...
Related contentRelated News
Beer Ingredient Eyed in Prostate Cancer Prevention
5 hours ago ago from Forbes.com
WEDNESDAY, Dec. 9 (HealthDay News) -- An ingredient of beer may someday help ward off prostate cancer, new animal experiments suggest. The compound in question, xanthohumol, is found in hops -- the bitter flavoring agent in beer -- and is known to block the male hormone testosterone, which plays a role in the development of prostate cancer. We hope that one day we can demonstrate that xanthohumol prevents prostate cancer development, ...
Related contentKids Who Beat Cancer Still Face Heart Risks
5 hours ago ago from Forbes.com
WEDNESDAY, Dec. 9 (HealthDay News) -- Survivors of childhood cancer have a significantly increased risk for developing heart disease as young adults, a new study finds. The finding came from an analysis of data on 14,358 five-year cancer survivors who were diagnosed before age 21 and 3,899 siblings of cancer survivors. The cancers were leukemia, brain cancer, Hodgkin s lymphoma, non-Hodgkin s lymphoma, kidney cancer, neuroblastoma, soft ...
Related contentGeron cancer drug meets midstage study goals
18 hours ago ago from FanHouse
MENLO PARK, Calif. -Biotechnology company Geron Corp. said Tuesday its developing cancer treatment GRNVAC1 met safety and tolerability goals in a midstage study. The drug candidate is actually a developing vaccine, aimed at prompting the immune system to fight tumor cells. The study involves patients with acute myelogenous leukemia, a type of blood and bone marrow cancer. Shares of Geron rose 12 cents, or 2 percent, to $6.02 in after-hours ...
Related contentSurprising Data Cause 10% Drop in Vertebroplasty and Vertebral Augmentation Procedures
2 hours ago ago from FanHouse
WALTHAM, Mass., Dec. 9 /PRNewswire/ -- Millennium Research Group (MRG), the global authority on medical technology market intelligence, finds that vertebroplasty and vertebral augmentation (which includes kyphoplasty) procedures have dropped 10% following the August 2009 publication of two studies in the New England Journal of Medicine (NEJM). The studies compared outcomes for osteoporotic vertebral compression fracture (VCF) patients treated ...
Related contentNCCN Guidelines for Non-Small Cell Lung Cancer Updated to Incorporate Maintenance Therapy
59 minutes ago ago from FanHouse
NCCN updates the NCCN Guidelines for Non-Small Cell Lung Cancer to include guidance on maintenance therapy, several new therapeutic recommendations for specific patients with Non-Small Cell Lung Cancer, and a revised staging system. FORT WASHINGTON, Pa., Dec. 9 /PRNewswire-USNewswire/ -- The National Comprehensive Cancer Network (NCCN) recently updated the NCCN Guidelines for Non-Small Cell Lung Cancer (NSCLC) to incorporate a new section ...
Related content
